Spreadsheet supplement to case 815055.

This is part of a three-case series that follows Dulcie Madden's journey as a founder over five years. Case (A) is about managing growth and cash flow; Case (B) is about the exit decision and conditions on a sale; Case (C) shows Madden dealing with adversity and the choice of "when to quit?" Rest Devices was an early stage company started by a team from MIT. Dulcie Madden decided to drop out of her MBA program at MIT to join Rest Devices as the CEO and use the innovative sensor technology to create a line of smart clothing for babies. A partnership with Babies "R" Us became a strong catalyst to growth but left Rest Devices increasingly constrained by additional capital requirements necessary to deliver the required number of units. As Madden tried to balance the need for capital with the business pressures of delivering a product for a nationwide rollout, she was faced with a series of strategic choices including an unsolicited acquisition offer, a lawsuit, failed financing, and tensions within the team.

Spreadsheet supplement for case 315046.

Spreadsheet supplement for case 315098.

Spreadsheet supplement for case 316154.

In July 2014, after 18 months and eight unsuccessful product launches, the CEO of Yabbly has agreed to sell his company to a larger, well-funded startup, providing a return of capital for his investors and a home for his team. Two weeks prior to the scheduled closing, the team launches a final experiment based on the results of a customer interview. After creating a quick landing page and announcing the product launch through social media channels, the company finds significant customer interest. With only two weeks of promising data, the CEO must decide whether or not to abandon the planned sale to pursue the new product, and if so, what terms he should offer new and existing investors to finance the next phase of product development.

Spreadsheet supplement for case 315082.

In this exercise, you will examine the cash flow implications of different operating model assumptions and the effect that this has on financing decisions.

Exercise to accompany "GenapSys: Business Models for the Genome".